메뉴 건너뛰기




Volumn 95, Issue 6, 2007, Pages 523-

Response: The value of sentinel lymph node biopsy in the management of head and neck melanoma [1]

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; DISEASE FREE SURVIVAL; HEAD AND NECK CANCER; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 34248177970     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20688     Document Type: Letter
Times cited : (1)

References (7)
  • 1
    • 4043175688 scopus 로고    scopus 로고
    • Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma
    • Thomas JM, Clark MA: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 2004;30:686-691.
    • (2004) Eur J Surg Oncol , vol.30 , pp. 686-691
    • Thomas, J.M.1    Clark, M.A.2
  • 2
    • 0141872351 scopus 로고    scopus 로고
    • Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years
    • Estourgie SH, Nieweg OE, Valdes Olmos RA, et al.: Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-688.
    • (2003) Ann Surg Oncol , vol.10 , pp. 681-688
    • Estourgie, S.H.1    Nieweg, O.E.2    Valdes Olmos, R.A.3
  • 3
    • 23844442115 scopus 로고    scopus 로고
    • Sentinel lymph node biopsy for melanoma: Prognostic value and disadvantages in 300 patients
    • de Vries M, Jager PL, Suurmeijer AJ, et al.: Sentinel lymph node biopsy for melanoma: Prognostic value and disadvantages in 300 patients. Ned Tijdschr Geneeskd 2005;149:1845-1851.
    • (2005) Ned Tijdschr Geneeskd , vol.149 , pp. 1845-1851
    • de Vries, M.1    Jager, P.L.2    Suurmeijer, A.J.3
  • 4
    • 23044501339 scopus 로고    scopus 로고
    • Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma
    • Kang JC, Wanek LA, Essner R, et al.: Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol 2005;23:4764-4770.
    • (2005) J Clin Oncol , vol.23 , pp. 4764-4770
    • Kang, J.C.1    Wanek, L.A.2    Essner, R.3
  • 5
    • 23044503344 scopus 로고    scopus 로고
    • The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes
    • Pawlik TM, Ross MI, Thompson JF, et al.: The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 2005;23:4588-4590.
    • (2005) J Clin Oncol , vol.23 , pp. 4588-4590
    • Pawlik, T.M.1    Ross, M.I.2    Thompson, J.F.3
  • 6
    • 24044509861 scopus 로고    scopus 로고
    • Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in clinical stage 1 melanoma
    • Morton DL, Thompson JF, Cochran AJ, et al.: Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in clinical stage 1 melanoma. J Clin Oncol 2005;23:S710.
    • (2005) J Clin Oncol , vol.23
    • Morton, D.L.1    Thompson, J.F.2    Cochran, A.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.